Zealthy Launches Dedicated Tirzepatide Care Pathway for Weight-Management Patients

New York, NY, June 23, 2026 (GLOBE NEWSWIRE) — Zealthy today announced the launch of a dedicated tirzepatide care pathway within its virtual weight-management platform.

Zealthy Launches Dedicated Tirzepatide Care Pathway for Weight-Management Patients

GLP-1s from Zealthy

The new workflow is designed to centralize the steps involved in evaluating eligible patients for prescription tirzepatide treatment. It includes an online medical assessment, review by a licensed healthcare provider, insurance coordination when applicable, prescription management and ongoing clinical communication.

The tirzepatide pathway is available to eligible patients through Zealthy’s online platform, subject to medical eligibility, state availability and provider judgment.

“This launch establishes a dedicated process for patients seeking an evaluation for tirzepatide treatment,” said a Spokesperson at Zealthy. “The workflow brings medical review, insurance coordination and follow-up care into one system while keeping prescribing decisions with licensed healthcare providers.”

Dedicated Online Evaluation Process

Patients entering the new care pathway begin by completing an online medical assessment.

The assessment collects information that may include:

  • Current height and weight
  • Existing medical conditions
  • Current prescriptions
  • Previous weight-management treatment
  • Allergies
  • Relevant personal and family medical history
  • Treatment goals
  • Insurance information

A licensed healthcare provider reviews the submitted information and determines whether additional documentation, laboratory testing or a virtual consultation is necessary.

The provider independently determines whether tirzepatide or another treatment is medically appropriate. Entering the pathway does not guarantee that a prescription will be issued.

Insurance Coordination

When a provider prescribes a treatment that requires insurance authorization, Zealthy’s care coordination team may assist with the applicable coverage process.

Support may include:

  • Verification of pharmacy benefits
  • Review of plan-specific requirements
  • Prior-authorization submissions
  • Collection of supporting clinical information
  • Responses to insurer documentation requests
  • Status updates during the review process
  • Prescription routing following approval

Insurance companies retain complete authority over coverage decisions, prior-authorization criteria, formularies and patient costs.

Zealthy does not guarantee that a medication will be covered or that a patient will qualify for a particular copay.

Prescription and Follow-Up Management

When treatment is approved by a licensed provider, the prescription may be sent to an eligible local, mail-order or dispensing pharmacy.

Patients can use Zealthy’s platform to communicate with their care team about:

  • Treatment instructions
  • Medication tolerance
  • Reported side effects
  • Refill requests
  • Follow-up evaluations
  • Provider-directed dosage changes
  • Treatment progress

Medication selection and dosage changes remain the responsibility of the prescribing healthcare provider.

The launch does not replace the need for individual clinical review. Tirzepatide treatment is not appropriate for every patient, and treatment availability may vary based on medical history, concurrent medications, location and applicable regulations.

Integration With Zealthy’s Weight-Management Program

The tirzepatide pathway operates within Zealthy’s existing virtual weight-management program.

Depending on the patient’s selected program and clinical needs, related services may include:

  • Medical-provider access
  • Prescription management
  • Insurance coordination
  • Secure provider messaging
  • Care coordination
  • Weight-management coaching
  • Nutrition and activity support
  • Ongoing treatment monitoring

The new pathway creates a defined process for tirzepatide evaluations while allowing providers to recommend another treatment when tirzepatide is not appropriate.

Availability

The dedicated tirzepatide care pathway is now available through Zealthy’s online weight-management platform.

Participation is subject to:

  • Completion of the required medical assessment
  • Review by a licensed healthcare provider
  • Clinical eligibility
  • State and pharmacy availability
  • Applicable prescribing and fulfillment requirements

No specific treatment outcome is guaranteed.

About Zealthy

Zealthy is an online healthcare platform that connects eligible patients with licensed medical providers for weight management and other healthcare services.

Its virtual-care programs may include medical evaluations, prescription management, insurance coordination, coaching and secure communication with a care team. Prescriptions are issued only when a licensed healthcare provider determines that treatment is medically appropriate.

Press Inquiries

support [at] getzealthy.com
https://getzealthy.com